4//SEC Filing
UPMC 4
Accession 0000899243-21-018109
CIK 0001785530other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 4:30 PM ET
Size
11.2 KB
Accession
0000899243-21-018109
Insider Transaction Report
Form 4
UPMC
10% Owner
Transactions
- Conversion
Series B Preferred Stock
2021-05-04−2,373,701→ 0 total→ Common Stock (273,811 underlying) - Conversion
Common Stock
2021-05-04+823,945→ 823,945 total - Conversion
Series A Preferred Stock
2021-05-04−7,142,857→ 0 total→ Common Stock (823,945 underlying) - Conversion
Common Stock
2021-05-04+273,811→ 1,097,756 total
Footnotes (2)
- [F1]On May 4, 2021, the Series A Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
- [F2]On May 4, 2021, the Series B Preferred Stock automatically converted into Common Stock on a 8.6691-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
Documents
Issuer
Werewolf Therapeutics, Inc.
CIK 0001785530
Entity typeother
IncorporatedPA
Related Parties
1- filerCIK 0001644244
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 4:30 PM ET
- Size
- 11.2 KB